Korea
LG Energy Solution and Hyundai Motor Group to Establish Battery Cell Manufacturing Joint Venture in the U.S.
* The new battery cell JV will be located in Bryan County, Savannah, Georgia where Hyundai Motor Group Metaplant America is currently being built * Total investment amount of over USD 4.3 billion; LGES and HMG to take a 50 percent stake respectively * JV's battery production aimed to start a...
2023-05-26 13:22
2273
Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine
* Elucidated molecular mechanism behind safety and efficacy of Bersiporocin * Bersiporocin is currently in Phase II clinical trial for Idiopathic Pulmonary Fibrosis SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEOLee Chang-jae and Jeon Sengho) announced on the 25th...
2023-05-26 06:00
2357
Lunit Demonstrates Predictive Value of AI-Biomarker Platform at the 2023 ASCO Annual Meeting
- New studies reveal Lunit SCOPE's impact on predicting clinical outcomes, analyzing tumor microenvironment, and enhancing personalized cancer treatment SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics soluti...
2023-05-26 05:00
2226
Hyundai Mobis Develops Groundbreaking Headlamps that Prevent Nighttime Accidents
* Displays real-time driving information on the road for drivers, and guides pedestrians to cross roads safely with a virtual crosswalk. * The system integrates with the camera sensor and GPS navigation to show various information and help drivers drive safely at night. * HD Lighting syste...
2023-05-25 20:00
2683
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
* HanAll Biopharma and Daewoong Pharmaceutical will co-develop NurrOn Pharmaceuticals' novel investigational compounds, including its lead asset ATH-399A, targeting Nurr1 for the treatment of Parkinson's disease (PD), as well as other neurodegenerative disorders * Phase 1 clinical trial is ex...
2023-05-25 19:00
2369
Kakao Entertainment blockbuster webtoon "A Business Proposal" set for US hardcopy release
NEW YORK, May 23, 2023 /PRNewswire/ -- Kakao Entertainment, in collaboration with a North American comics publisher, is set to release a hardcopy edition of its global blockbuster webtoon, "A Business Proposal." The new print edition will be available in major North American bookstores, including...
2023-05-23 21:00
2824
KCI, a subsidiary of Samyang Group, has been awarded a 'Gold Medal' in EcoVadis' ESG Rating, placing the company in the top 5% worldwide.
SEOUL, South Korea, May 23, 2023 /PRNewswire/ -- KCI Ltd., a subsidiary of Samyang Group specializing in cosmetics and personal care materials, has been awarded 'Gold Medal' status in the 2023 Sustainability Rating from 'EcoVadis,' the world's largest ESG rating organization. This prestigious rec...
2023-05-23 20:30
2155
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum
* Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global vaccine accessibility, claiming the importance of international cooperation to establish a regional-based vaccine hub at the Regionalized Vaccine Manufacturing Collaborative Side Event. SEONGNAM, Sout...
2023-05-23 20:00
2085
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
DAEJEON, South Korea, May 23, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company received IND (Investigational New Drug) approval from the Korean MFDS (Mi...
2023-05-23 20:00
1766
Representative K-pop co-ed group KARD releases new album
"Comeback D-day" KARD, releasing 6th mini-album ICKY on May 23! (KST) "Intense and Dynamic" free-spirited energy... Shows their true wild side! "Representative K-pop co-ed group" KARD, releasing 6th mini-album ICKY! Challenging with unique concepts... Showing KARD's confidence in the new release...
2023-05-23 17:00
2257
Smilegate Launches New Mobile RPG 'OUTERPLANE' Globally
SEOUL, South Korea, May 22, 2023 /PRNewswire/ -- Smilegate globally released its highly anticipated new mobile turn-based role-playing game (RPG) 'OUTERPLANE'. The game is now available in multiple languages, including Korean, English, and Chinese (Simplified and Traditional) in over 170 countrie...
2023-05-23 10:00
2240
LG Display Recognized for Pioneering Research on Ultra-large OLED and Stretchable Displays at SID 2023
SEOUL, South Korea, May 20, 2023 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that two of its research papers on 'ultra-large OLED display' and 'Stretchable display' have been selected as Distinguished Papers by the Society for Information Dis...
2023-05-21 09:00
3439
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial
* Positive primary endpoint result of objective response rate (ORR) from the planned interim analysis of Phase II trial in advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJ). * Top-line data of the final analysis from Phase II to be announced in the second half of next year. S...
2023-05-19 21:00
2383
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023
- New investigational data evaluating Fexuprazan in a Korean clinical trial program for healing erosive esophagitis (EE) regardless of food intake, and in a Chinese pivotal clinical trial program for the treatment of EE SEOUL, South Korea and CHICAGO, May 19, 2023 /PRNewswire/ -- Daewoong Pharm...
2023-05-19 20:00
2256
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease
* Tanfanercept did not demonstrate statistical significance in either of the primary outcome measures of improvement in central corneal staining score (CCSS) or in improvement in Eye Dryness Score (EDS) assessed at week 8 in subjects with dry eye disease (DED), compared to vehicle. * However,...
2023-05-19 19:00
2061
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)
- The first plant stem cell-derived exosome patent in the US - The 5th patent allowance following 3 in Korea and 1 in Japan - An important milestone for the global plant stem cell-derived exosome industry SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- ExoCoBio, one of the top three exosome...
2023-05-19 16:34
3865
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA
- Flagship products Neurophet AQUA and Neurophet SCALE PET both received 510k - Plans to cooperate with radiology AI solution platform companies to enter the U.S. market SEOUL, South Korea, May 18, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease...
2023-05-18 21:00
2174
Samsung Electro-Mechanics develops the world's highest capacity MLCC for electric vehicles
* Development of two types of MLCCs applied to electric vehicles...Realization of the industry's highest capacity among MLCCs with a rated voltage in the 250·100V class * Rated voltage: The maximum voltage that can be withstood without being damaged by the voltage. - Used in electric systems ...
2023-05-17 18:34
2372
Amorepacific Holds the Skin Epigenetics Symposium at the International Societies for Investigative Dermatology 2023
SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- Amorepacific held the "Skin Epigenetics – Sulwhasoo Symposium" at International Societies for Investigative Dermatology Meeting 2023 (ISID 2023) inTokyo, Japan. During the symposium on May 11 (Thursday), under the theme of skin epigenetics, Amorepa...
2023-05-16 21:00
2033
MAXST, expanded application of AR glasses through global technological cooperation with EPSON
SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- MAXST (KRX: 377030, KQ) announced onMay 16th that they have developed and distributed a customized AR development solution for the new augmented reality (AR) smart glasses released byJapan's Seiko Epson Corporation (referred to as Epson). With the ...
2023-05-16 20:00
2118
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
